Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Cytomegalovirus Infection

  Free Subscription

Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 15 articles:
HTML format
Text format

Single Articles

    November 2016
  1. ISHIDA JH, Patel A, Mehta AK, Gatault P, et al
    Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01794.
    PubMed     Text format     Abstract available

    June 2016
  2. PATEL HD, Nikitin P, Gesner T, Lin JJ, et al
    In vitro characterization of human cytomegalovirus-targeting therapeutic monoclonal antibodies LJP538 and LJP539.
    Antimicrob Agents Chemother. 2016 Jun 6. pii: AAC.00382.
    PubMed     Text format     Abstract available

    May 2016
  3. CHEN H, Li C, Zemlicka J, Gentry BG, et al
    Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.
    Antimicrob Agents Chemother. 2016 May 2. pii: AAC.00449.
    PubMed     Text format     Abstract available

    April 2016
  4. CHOU S, Ercolani RJ, Lanier ER
    Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected in Vitro that Confer Brincidofovir Resistance.
    Antimicrob Agents Chemother. 2016 Apr 4. pii: AAC.00214.
    PubMed     Text format     Abstract available

  5. PADULLES A, Colom H, Bestard O, Melilli E, et al
    Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients.
    Antimicrob Agents Chemother. 2016;60:1992-2002.
    PubMed     Text format     Abstract available

    February 2016
  6. DOLE K, Segal FP, Feire A, Magnusson B, et al
    A first-in-human study to assess the safety and pharmacokinetics of monoclonal antibodies against human cytomegalovirus in healthy volunteers.
    Antimicrob Agents Chemother. 2016 Feb 29. pii: AAC.02698.
    PubMed     Text format     Abstract available

    November 2015
  7. VAZQUEZ JA, Manavathu EK
    Molecular Characterization of a Voriconazole-resistant, Posaconazole-susceptible, Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Antimicrob Agents Chemother. 2015 Nov 16. pii: AAC.01130.
    PubMed     Text format     Abstract available

    August 2015
  8. CHOU S
    Rapid in Vitro Evolution of Human Cytomegalovirus UL56 Mutations that Confer Letermovir Resistance.
    Antimicrob Agents Chemother. 2015 Aug 10. pii: AAC.01623.
    PubMed     Text format     Abstract available

    June 2015
  9. ISHIDA JH, Burgess T, Derby M, Brown PA, et al
    Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anti-Cytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.
    Antimicrob Agents Chemother. 2015 Jun 8. pii: AAC.00523.
    PubMed     Text format     Abstract available

    April 2015
  10. ROY S, He R, Kapoor A, Forman M, et al
    Inhibition of Human Cytomegalovirus (CMV) Replication by Artemisinins- Effects Mediated through Cell Cycle Modulation.
    Antimicrob Agents Chemother. 2015 Apr 13. pii: AAC.00262.
    PubMed     Text format     Abstract available

  11. HUTTERER C, Eickhoff J, Milbradt J, Korn K, et al
    A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.
    Antimicrob Agents Chemother. 2015;59:2062-71.
    PubMed     Text format     Abstract available

    March 2015
  12. WILDUM S, Zimmermann H, Lischka P
    In vitro drug combination studies of letermovir (AIC246, MK-8228) with approved anti Human Cytomegalovirus (HCMV) and HIV compounds in inhibition of HCMV and HIV replication.
    Antimicrob Agents Chemother. 2015 Mar 16. pii: AAC.00114.
    PubMed     Text format     Abstract available

    December 2014
  13. KAUVAR LM, Liu K, Park M, DeChene N, et al
    A High Affinity Native Human Antibody Neutralizes Human Cytomegalovirus Infection of Diverse Cell Types.
    Antimicrob Agents Chemother. 2014 Dec 22. pii: AAC.04295.
    PubMed     Text format     Abstract available

    October 2014
  14. DONALISIO M, Ranucci E, Cagno V, Civra A, et al
    Agmatine-containing poly(amidoamine)s as a novel class of antiviral macromolecules: structural properties and in vitro evaluation of infectivity inhibition.
    Antimicrob Agents Chemother. 2014;58:6315-9.
    PubMed     Text format     Abstract available

    September 2014
  15. TAVIS JE, Wang H, Tollefson AE, Ying B, et al
    Inhibitors of nucleotidyl transferase superfamily enzymes suppress herpes simplex virus replication.
    Antimicrob Agents Chemother. 2014 Sep 29. pii: AAC.03875.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.